Assessing patients with lupus: towards a drug responder index (Q33771499)

29 July 2017

1 reference

title

Assessing patients with lupus: towards a drug responder index (English)

1 reference

29 July 2017

1

Isenberg D

1 reference

29 July 2017

Rosalind Ramsey-Goldman

series ordinal

2

object named as

Ramsey-Goldman R

1 reference

29 July 2017

publication date

1 November 1999

1 reference

29 July 2017

1 reference

29 July 2017

volume

38

1 reference

29 July 2017

issue

11

1 reference

29 July 2017

page(s)

1045-1049

1 reference

Measurement of systemic lupus erythematosus activity in clinical research

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F38.11.1045

Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F38.11.1045

The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F38.11.1045

Systemic lupus erythematosus in three ethnic groups: III. A comparison of characteristics early in the natural history of the LUMINA cohort. LUpus in MInority populations: NAture vs. Nurture

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F38.11.1045

Standards for validating health measures: definition and content

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F38.11.1045

Validating the SF-36 health survey questionnaire: new outcome measure for primary care

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F38.11.1045

The SF36 health survey questionnaire: an outcome measure suitable for routine use within the NHS?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F38.11.1045

A double-blind, placebo-controlled, clinical trial of dehydroepiandrosterone in severe systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F38.11.1045

10.1093/RHEUMATOLOGY/38.11.1045

21 January 2018

Identifiers

DOI

1 reference

29 July 2017

1 reference